SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : The Naked Truth - Big Kahuna a Myth

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Lucretius who wrote (18411)2/7/1999 12:46:00 AM
From: IceShark   of 86076
 
Jeez Luc, you should have told us that your predictions may vary a bit on timing since you were going through a change. Pleeeease don't volunteer for this kinda stuff again - go back to donating blood for your ThunderChicken tab. -vbg-

Studies on psychosis in mentally ill to be suspended

February 6, 1999
Web posted at: 6:41 PM EST (2341 GMT)

BOSTON (AP) -- A federal agency has suspended controversial psychosis
studies after it came under fire for using a powerful hallucinogen on healthy volunteers and mentally ill patients.

Dr. Steven E. Hyman, head of the National Institute of Mental Health in Bethesda, Md., has suspended tests on ketamine, known on the streets as "Special K."

The drug is approved by the Food and Drug Administration for use as an
anesthetic, but is sold on the streets as a hallucinogenic.

"We are not going to be funding research that will produce harm," Hyman said at a meeting of the National Advisory Mental Health Council.

Researchers have given ketamine to people with mental illness and healthy volunteers to study the biology of psychoses.


snip the rest of the story
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext